These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14583773)

  • 81. Aspirin and reduced risk of esophageal carcinoma.
    Funkhouser EM; Sharp GB
    Cancer; 1995 Oct; 76(7):1116-9. PubMed ID: 8630885
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort.
    Dhillon PK; Kenfield SA; Stampfer MJ; Giovannucci EL; Chan JM
    Cancer Prev Res (Phila); 2012 Oct; 5(10):1223-8. PubMed ID: 22961777
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Low-dose aspirin use and cancer characteristics: a population-based cohort study.
    Jonsson F; Yin L; Lundholm C; Smedby KE; Czene K; Pawitan Y
    Br J Cancer; 2013 Oct; 109(7):1921-5. PubMed ID: 23887604
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study.
    Gierach GL; Lacey JV; Schatzkin A; Leitzmann MF; Richesson D; Hollenbeck AR; Brinton LA
    Breast Cancer Res; 2008; 10(2):R38. PubMed ID: 18447943
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Nonnarcotic analgesic use and the risk of hypertension in US women.
    Dedier J; Stampfer MJ; Hankinson SE; Willett WC; Speizer FE; Curhan GC
    Hypertension; 2002 Nov; 40(5):604-8; discussion 601-3. PubMed ID: 12411450
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A prospective study of aspirin use and primary prevention of cardiovascular disease in women.
    Manson JE; Stampfer MJ; Colditz GA; Willett WC; Rosner B; Speizer FE; Hennekens CH
    JAMA; 1991 Jul 24-31; 266(4):521-7. PubMed ID: 2061978
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pre-diagnosis and post-diagnosis use of common analgesics and ovarian cancer prognosis (NHS/NHSII): a cohort study.
    Merritt MA; Rice MS; Barnard ME; Hankinson SE; Matulonis UA; Poole EM; Tworoger SS
    Lancet Oncol; 2018 Aug; 19(8):1107-1116. PubMed ID: 30029888
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Lung cancer death rates by smoking status: comparison of the Three-Prefecture Cohort study in Japan to the Cancer Prevention Study II in the USA.
    Marugame T; Sobue T; Satoh H; Komatsu S; Nishino Y; Nakatsuka H; Nakayama T; Suzuki T; Takezaki T; Tajima K; Tominaga S
    Cancer Sci; 2005 Feb; 96(2):120-6. PubMed ID: 15723657
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The association of aspirin use with overall survival of patients with inoperable non-small cell lung cancer: a retrospective study.
    Chuang MC; Yang YH; Hsieh MJ; Lin YC; Yang TM; Chen PC; Hung MS
    BMC Cancer; 2021 Nov; 21(1):1257. PubMed ID: 34809588
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Nonsteroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa women's health study.
    Mahipal A; Anderson KE; Limburg PJ; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1785-90. PubMed ID: 17035383
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Incident cancer risk after the start of aspirin use: results from a Dutch population-based cohort study of low dose aspirin users.
    Hollestein LM; van Herk-Sukel MP; Ruiter R; de Vries E; Mathijssen RH; Wiemer EA; Stijnen T; Coebergh JW; Lemmens VE; Herings RM; Stricker BH; Nijsten T
    Int J Cancer; 2014 Jul; 135(1):157-65. PubMed ID: 24285345
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Aspirin use and prostate tumor angiogenesis.
    Fu BC; Wang K; Mucci LA; Clinton SK; Giovannucci EL
    Cancer Causes Control; 2022 Jan; 33(1):149-151. PubMed ID: 34626297
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Lung cancer and regular use of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs.
    Kelly JP; Coogan P; Strom BL; Rosenberg L
    Pharmacoepidemiol Drug Saf; 2008 Apr; 17(4):322-7. PubMed ID: 18041807
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Aspirin and lung cancer risk in a cohort study of women: dosage, duration and latency.
    Feskanich D; Bain C; Chan AT; Pandeya N; Speizer FE; Colditz GA
    Br J Cancer; 2007 Nov; 97(9):1295-9. PubMed ID: 17895894
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.
    Cook NR; Lee IM; Gaziano JM; Gordon D; Ridker PM; Manson JE; Hennekens CH; Buring JE
    JAMA; 2005 Jul; 294(1):47-55. PubMed ID: 15998890
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Low-dose aspirin and incidence of lung carcinoma in patients with chronic obstructive pulmonary disease in Hong Kong: A cohort study.
    Yu SY; Ip MS; Li X; Cheung KS; Ren QW; Wu MZ; Li HL; Wong PF; Tse HF; Yiu KH
    PLoS Med; 2022 Jan; 19(1):e1003880. PubMed ID: 35025879
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Aspirin overcomes cisplatin resistance in lung cancer by inhibiting cancer cell stemness.
    Zhao M; Wang T; Hui Z
    Thorac Cancer; 2020 Nov; 11(11):3117-3125. PubMed ID: 32991066
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Association between the use of aspirin and risk of lung cancer: results from pooled cohorts and Mendelian randomization analyses.
    Jiang Y; Su Z; Li C; Wang R; Wen Y; Liang H; He J; Liang W
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):139-151. PubMed ID: 32965542
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Association of Long-term Use of Low-Dose Aspirin as Chemoprevention With Risk of Lung Cancer.
    Ye S; Lee M; Lee D; Ha EH; Chun EM
    JAMA Netw Open; 2019 Mar; 2(3):e190185. PubMed ID: 30821825
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.